John Mandrola reacts to evidence suggesting about one in four patients on thyroid replacement could discontinue therapy, and wonders whether placebo-controlled discontinuation would show even higher rates and apply to other medications.
I, naively, assumed all pts on thyroid replacement needed it.
Gosh, 1 in 4 pts could stop the med
I bet if you used a proper placebo the discontinuation rate would be even higher
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare